# Trade Mark Journal No.2026/020 15 May 2026

## WO0000001915559 (5)

Office of origin: United States of America

Date of International Registration:2 April 2026
Date of designation in the UK: 2 April 2026

International priority date claimed: 8 October 2025 (United States of America) (99432489)

Class 5
  Pharmaceutical preparations for the treatment of eye diseases and conditions.

Tenpoint Therapeutics Holding Limited

Representative: Joshua G. Gigger STOEL RIVES, 201 South Main Street,, Suite 205, Salt Lake City UT 84111, UNITED STATES OF AMERICA